Brief: Sorrento Announces Covistix Covid-19 Rapid Antigen Detection Test Detects Omicron Variant

Sorrento Therapeutics

27/12/2021 14:30

Dec 27 (Reuters) - Sorrento Therapeutics Inc  SRNE.O :
    * SORRENTO ANNOUNCES COVISTIX COVID-19 VIRUS RAPID ANTIGEN
DETECTION TEST DETECTS OMICRON VARIANT
    * SORRENTO - IN DISCUSSIONS WITH MULTIPLE U.S. STATES FOR
INCENTIVE PACKAGES TO FURTHER EXPAND MANUFACTURING CAPACITY
PENDING DEMAND FOR COVISTIX TESTS
    * SORRENTO THERAPEUTICS INC - CURRENTLY HAS CAPACITY TO
PRODUCE 30
MILLION COVISTIX TESTS A MONTH AND IS BUILDING UP ITS
MANUFACTURING CAPACITY IN U.S.
    * SORRENTO THERAPEUTICS - PENDING U.S. & GLOBAL DEMAND,
CAPACITY
TO PRODUCE COVISTIX TEST COULD POTENTIALLY BE INCREASED TO OVER
100 MILLION MONTHLY IN 2022

Source text for Eikon:  ID:nGNX8tVyYC 
Further company coverage:  SRNE.O 

 ((Reuters.Briefs@thomsonreuters.com;))